Hollow needle
Abstract
This record has no abstract on file.
Term
Projected expiry 3 February 2029.
- Priority
- Filed
- Published
- Today
- Projected expiry
15 claims: 3 independent, 12 dependent
- 1Claims of equivalent WO 2009098024 A2 CLAIMS 1. A hollow needle for attachment to a syringe, through which a liquid can be delivered to the stratum granulosum and/or beneath the epidermis, preferably to an area consisting from the stratum granulosum (included) to reticular dermis (included) and more preferably beneath the papillary dermisduring a cosmetic procedure, the needle comprising a distal tip and including a lateral aperture adjacent to the distal tip, wherein the liquid exits the needle via the lateral aperture, wherein the needle is flexible and wherein the distal tip of the needle is blunt.
- 10A needle according any preceding claim, wherein it is totally or partially in stainless steel or in a shape memory alloy (SMA) .
- 11Apparatus for delivering a liquid to the stratum granulosum and/or beneath the epidermis, preferably to an area consisting from the stratum granulosum (included) to reticular dermis (included) and more preferably beneath the papillary dermis during a cosmetic procedure, comprising a syringe and a needle according to any of claims 1 to 4.
Independent claims3
33 paragraphs in 1 section, as filed
Description of equivalent WO 2009098024 A2
INSTRUMENTS
Field of the Invention
The present invention relates to needles for delivering a liquid to the stratum granulosum and/or beneath the epidermis, preferably to an area consisting from the stratum granulosum (included) to reticular dermis (included) and more preferably beneath the papillary dermis during an injection procedure and more preferably during a cosmetic procedure.
Background of the Invention
Many cosmetic procedures carried out on the skin involve the injection of a liquid beneath the epidermis. An example of such a liquid is hyaluronic acid. For injection beneath the epidermis, the needle may pass through the stratum papillaire. The stratum papillaire contains a network of blood vessels that, if severed, may lead to facial bruising.
Injections of a liquid into the stratum granulosum and/or beneath the epidermis during a cosmetic procedure are traditionally carried out using a conventional sharp pointed needle. One example of such a needle is a 25G needle, which has a diameter of 0.5 mm. Due to its sharp tip, the depth of penetration is difficult to control, and the needle can cut the deep-lying tissues of the skin. In particular, the needle may sever the cellular tissues, the elastic and collagen fibers, and the fine blood and lymph vessels. As the depth of penetration is difficult to control, the administration may not be precise, and the cosmetic procedure may therefore be less effective than desired.
A cosmetic treatment to the skin may require several injections of a liquid. Before each injection with a conventional sharp-tipped needle, anaesthesia is required. This may require a block over a large area. Summary of the Invention
The present invention is based on the discovery that, by using a flexible needle with a blunt tip, liquid can be delivered over a large area of the stratum granulosum and/or beneath the epidermis, preferably to an area consisting from the stratum granulosum (included) to reticular dermis (included) and more preferably beneath the papillary dermis, through one micro-incision or preferably through a tiny hole previously made with a classic needle. This means that the amount of anaesthesia needed before a cosmetic procedure may be reduced by 10 to 15- fold. As the needle is blunt and flexible, the risk of severing the blood vessels underneath the epidermis may also be reduced and the risk of intravascular injection is abolished. The combination of this advantages leads to a shortening of the cosmetic procedure and of the period of recovery.
According to a first aspect, the present invention is a hollow needle for attachment to a syringe, through which a liquid can be delivered to the stratum granulosum and/or beneath the epidermis, preferably to an area consisting from the stratum granulosum (included) to reticular dermis
(included) and more preferably beneath the papillary dermis during a cosmetic procedure, the needle comprising a distal tip and including a lateral aperture adjacent to the distal tip, wherein the liquid exits the needle via the lateral aperture, and wherein the needle is flexible.
It is know from application US2001/003709 a rigid and curved canulae for injections into muscle comprising a distal tip and including a lateral aperture adjacent to the distal tip. These canulaes have a diameter of 1.5 mm. They are totally different from the needle according to the invention which is flexible, preferably straight and has preferably a far smaller diameter. Furthermore the needle according to the invention allows preferably the injection of a liquid to an area consisting from the stratum granulosum (included) to reticular dermis (included)) whereas the canulae according to US2001/003709 is strictly dedicated to the injection into muscles.
According to a second aspect, the present invention is an apparatus for delivering a liquid to the stratum granulosum and/or beneath the epidermis, preferably to an area consisting from the stratum granulosum (included) to reticular dermis (included) and more preferably beneath the papillary dermis during a cosmetic procedure, comprising a syringe and a needle, as defined above. According to a preferred embodiment, the needle according to the invention is straight.
According to a third aspect, the present invention is a method of delivering a liquid to the stratum granulosum and/or beneath the epidermis, preferably to an area consisting from the stratum granulosum (included) to reticular dermis (included) and more preferably beneath the papillary dermis during a cosmetic procedure, using apparatus, as defined above.
According to a fourth aspect, the present invention is a method of treatment comprising the use of a method of delivering a liquid as defined above.
Description of Preferred Embodiments
The invention will now be illustrated by way of example only with reference to the following drawings.
Figure 1 shows a schematic lateral section of a needle embodying the present invention. The needle (3) includes a hollow base section (4), which may be made of a plastics material. This base section (4) allows the needle to be attached to a syringe containing a liquid for subepidermal administration. The needle (3) has a lateral aperture (2), through which the liquid is delivered. The distal tip (1) of the needle is blunt.
The length of a needle according to the invention is preferably between 13 and 45 mm. In another preferred embodiment, the length of the needle is less than 50 mm, more preferably between 5 and 50mm. In a further preferred embodiment, the length of the needle is approximately 47, 40 mm, 37, 27, 20,17, 13 and 10 .
A needle according to the invention preferably has a diameter of between 0.3 and 0.7 mm. More preferably, the diameter is less 0.5, 0.4 or 0.3 mm. More preferably still, the needle has a diameter of approximately 0.5 mm, 0.4 mm, 0.3 mm, 0.2 mm, between 0.2 and 0.3 mm, between 0.3 and 0.4 mm. or between 0.4 and 0.5 mm. The fine diameter of the needle may help to reduce the risk of severing the blood vessels.
Due to the lateral aperture, the tip of the needle is blunt. Preferably, the tip of needle is rounded. This may reduce the trauma to the patient. The lateral length of the aperture is preferably approximately equal to 0.5 mm. In a preferred embodiment, the aperture is located approximately 1 mm from the distal tip of the needle. According to another preferred embodiment, the aperture is located at most at 2mm from the distal tip of the needle and even more preferably between 0.05 mm and 2 mm from the distal tip of the needle and according to a definitely preferred embodiment between 0.05 mm and 0.5 mm from the distal tip of the needle.
According to a preffered embodiment, the needle according to the invention has only one lateral aperture and has no aperture at its distal tip.
The size of the larger diameter of the lateral aperture is preferably comprised between 0.01 and 1 mm more preferably between 0.01 and 0.2 mm, even more preferably between 0.01 and 0.1 mm. The one skilled in the art is able to determine the most accurate size in regard of the viscosity for each liquid to be injected and of the specific therapeutic use.
According to a preferred embodiment, the hollow base section of the needle according to the invention further comprises a sign (e.g. a color spot) and preferably at the same radial position than the lateral aperture. This sign allows knowing the position of the lateral aperture even when the needle is in position under the skin of a patient.
A needle of the invention is flexible, meaning that it may be able to glide through the layers of the skin without damaging the underlying tissues, or cutting the blood vessels. This may help to reduce the amount of bruising after a particular cosmetic procedure. According to a more preferred embodiment, the term "flexible" means that the needle according to the invention can be bend to an angle of 60° relative to its longitudinal axis, by applying a force to the distal tips which is less than 5N .
The needle according to the invention can be made totally or partially in stainless steel. According to another embodiment of the invention can be totally or partially made of a shape memory alloy (SMA) . The use of such SMA allows producing a needle which can return to a specific shape when it is submitted to the body temperature. According to a preferred embodiment, the needle of the invention is partially or totally made of nitinol . Due to the flexibility of a needle of the invention, and the resistance offered by the deeper layers of the skin, a liquid can be delivered to the stratum granulosum over a large area, and in an even manner, through one single micro-incision of the skin. The tension of the deep- lying layers of skin prevents the blunt needle from penetrating into those layers, and causes it to "curve" into the stratum granulosum and/or beneath the epidermis, preferably to an area consisting from the stratum granulosum (included) to reticular dermis (included) and more preferably beneath the papillary dermis.
The user may be able to manipulate the needle in a "circular" motion, in order to maximize the area of delivery of the liquid. Due to the construction of the needle, it can glide under the skin with ease. This may significantly reduce the pain and trauma to the patient.
Further, as a needle of the invention is able to deliver a liquid to a large area, through one single initial micro-incision, a dosage of anaesthetic to that single micro-incision site may provide sufficient anaesthesia for the injection of all the liquid required for the cosmetic procedure. If a conventional sharp-tipped, inflexible needle were used, several micro-incisions, and several dosages of anaesthetic would normally be required.
By way of example, a cosmetic treatment using conventional sharp-tipped needles may require a dosage of anaesthetic at 20 different sites followed by 20 injections of a liquid such as hyaluronic acid, into each those sites. The same procedure using a needle of the invention may require anaesthetic to be administered to a single site only, followed by a single injection of hyaluronic through one single micro-incision. Due to the construction of the needle, the same area can be treated, as if the procedure was carried utilising the conventional method. The requirement far one micro-incision only may greatly reduce the negative side-effects of the cosmetic procedure, such as bruising and scarring. The procedure may also be more precise, leading to more aesthetically pleasing results. In one embodiment, a kit is provided, comprising a needle of the invention and a syringe. The syringe may contain the liquid medicament, an example al which is hyaluronic acid. Alternatively, the medicament may be provided separately. In another embodiment, the needle of the invention and the syringe may be integral.
According to another embodiment, the present invention is a method of delivering a liquid to the stratum granulosum and/or beneath the epidermis, preferably to an area consisting from the stratum granulosum (included) to reticular dermis (included) and more preferably beneath the papillary dermis, using apparatus, as defined above. According to a preferred embodiment, the liquid to be delivered is a filler liquid and more preferably is hyaluronic acid. According to another preferred embodiment the liquid to be delivered is a anaesthetic and more preferably is lidocaϊn.
According to another embodiment, the present invention is a method of treatment comprising the use of a method of delivering a liquid as defined above. According to a preferred embodiment, the treatment is a cosmetic procedure or anaesthesia.
The following Example illustrates the invention.
Example
After disinfecting the skin, a small quantity Of anaesthetic is injected (10 tol5 times less than the usual amount when using conventional needles) . One single micro- incision is then created using a conventional 25G or 26G needle. This micro-incision should be placed in the centre of the area to be treated. The entire length of a needle according to the invention is then inserted laterally into the stratum granulosum through this micro-incision, and the desired liquid (for example, reticulated hyaluronic acid) is injected beneath the skin. The injection is then repeated in a radial pattern, resembling the "spokes-of-a- wheel", always starting from the same initial micro- incision. Bruising is greatly reduced compared with a conventional procedure, using sharp-tipped needles.
Every citation, both waysCites: the store holds 2 of 3
| Document | Relation | Office | Cited during |
|---|---|---|---|
| US6135984A | Cites | United States of America | Third party observation |
| US6162202A | Cites | United States of America | Examiner |
12 members in 7 offices
Priority claims17
| Document | Office | Kind | Date |
|---|---|---|---|
| 0800583 | France | A | |
| 0800583 | France | – | |
| 66501P | United States of America | – | |
| 6650108 | United States of America | P | |
| 08103053 | European Patent Office (EPO) | A | |
| 08103053 | European Patent Office (EPO) | – | |
| 09708469 | European Patent Office (EPO) | A | |
| 2009000698 | European Patent Office (EPO) | W | |
| 0800583 | – | – | – |
| 08103053 | – | – | – |
| 66501P | – | – | – |
| EP20080103053 | – | – | – |
| EP2009000698 | – | – | – |
| EP20090708469 | – | – | – |
| FR20080000583 | – | – | – |
| US20080066501P | – | – | – |
| WO2009EP00698 | – | – | – |
Members12
| Document | Office | Kind | |
|---|---|---|---|
| FR2926997A1 | France | A1 | |
| WO2009098024A2 | World Intellectual Property Organization (WIPO) | A2 | |
| EP2105155A1 | European Patent Office (EPO) | A1 | |
| WO2009098024A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP2249906A2This record | European Patent Office (EPO) | A2 | |
| US2010324530A1 | United States of America | A1 | |
| CN101939037A | China | A | |
| JP2011510715A | Japan | A | |
| FR2926997B1 | France | B1 | |
| US2013102956A1 | United States of America | A1 | |
| JP5518742B2 | Japan | B2 | |
| BRPI0907448A2 | Brazil | A2 |
16 legal events, as 2 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Application refused18R | 18R | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: THE APPLICATION HAS BEEN REFUSEDSTAA | STAA | EP | |
| Refusal decision now finalR003 | R003 | DE | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Request for extension of the european patent (deleted)DAX | DAX | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Observations by third partiesORIGINAL CODE: EPIDOSNTIPATPAC | TPAC | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Request for extension of the european patentAX | AX | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 2249906
- Publication, DOCDB
- 2249906
- Publication, EPODOC
- EP2249906
- Application
- 9708469
- Application, DOCDB
- 09708469
- Application, EPODOC
- EP20090708469
Titles3
- German
- HOHLNADEL
- English
- HOLLOW NEEDLE
- French
- AIGUILLE CREUSE
Classification
- CPC, 7
- A61M5/3287
- A61M5/2053
- A61B2017/00792
- A61M5/329
- A61M5/3291
- A61M5/422
- A61M2005/341
- IPC, 3
- A61M5 32
- A61B17 00
- A61M5 20
Designated states38
- Contracting states, 35
- Austria
- Belgium
- Bulgaria
- Switzerland
- Cyprus
- Czechia
- Germany
- Denmark
- Estonia
- Spain
- Finland
- France
- United Kingdom
- Greece
- Croatia
- Hungary
- Ireland
- Iceland
- Italy
- Liechtenstein
- Lithuania
- Luxembourg
- Latvia
- Monaco
and 11 moreShow fewer
- North Macedonia
- Malta
- Netherlands (Kingdom of the)
- Norway
- Poland
- Portugal
- Romania
- Sweden
- Slovenia
- Slovakia
- Türkiye
- Extension states, 3
- Albania
- Bosnia and Herzegovina
- Serbia